LUXH Overview

DoubleVerify Holdings Investigation: Grabar Law Office is investigating potential breaches of fiduciary duties by officers and directors of DoubleVerify Holdings, Inc. (NYSE: DV) related to undisclosed issues affecting the company's advertising services and financial disclosures.

LuxUrban Hotels Investigation: An investigation is underway regarding LuxUrban Hotels Inc. (OTC: LUXH) for allegedly misleading statements and undisclosed lawsuits, with shareholders encouraged to seek corporate reforms and potential returns.

RCI Hospitality Holdings Allegations: RCI Hospitality Holdings, Inc. (NASDAQ: RICK) faces scrutiny for alleged tax fraud and bribery by its executives, leading to materially false financial statements, with affected shareholders advised to participate in legal actions.

Treace Medical Concepts Claims: Treace Medical Concepts, Inc. (NASDAQ: TMCI) is under investigation for failing to disclose competitive impacts on its primary product, with shareholders encouraged to seek corporate reforms and returns.

Investigation Announcement: Kahn Swick & Foti, LLC has initiated an investigation into LuxUrban Hotels Inc. following allegations of failing to disclose material information regarding a lease agreement with the Royalton Hotel and ongoing lawsuits for unpaid rent.

Legal Proceedings: LuxUrban and its executives are facing a securities class action lawsuit for violating federal securities laws, with a recent court ruling allowing the case to proceed after denying the company's motion to dismiss.

Applied Therapeutics Class Action Settlement: A securities fraud class action against Applied Therapeutics has reached a settlement, allowing shareholders who purchased shares before January 3, 2024, to seek corporate reforms and a court-approved incentive award at no cost.

DoubleVerify Holdings Investigation: Grabar Law Office is investigating potential breaches of fiduciary duties by officers of DoubleVerify Holdings, with allegations of misleading statements regarding the company's ad spending and technological capabilities affecting shareholder rights.

LuxUrban Hotels Class Action Update: A securities fraud class action against LuxUrban Hotels has survived a motion to dismiss, with allegations of false statements about hotel leases and financial misrepresentations, allowing shareholders who purchased shares before November 8, 2023, to seek corporate reforms.

Unicycive Therapeutics Investigation: Grabar Law Office is investigating Unicycive Therapeutics for potential securities fraud, with claims that the company overstated its compliance with FDA manufacturing requirements, impacting shareholders who purchased shares before March 29, 2024.

Flywire Corporation Investigation: Grabar Law Office is investigating claims against Flywire Corporation's officers and directors for potential breaches of fiduciary duties, with a focus on misleading statements regarding the company's revenue growth and business impacts from permit and visa restrictions.

iRobot Corporation Class Action: iRobot Corporation faces allegations of making false statements about its operational restructuring following the termination of its acquisition by Amazon, leading to doubts about its ability to operate profitably as a standalone company.

LuxUrban Hotels Inc. Lawsuit: LuxUrban Hotels is under investigation for allegedly providing misleading information about its business operations, including unverified hotel leases and ongoing lawsuits, which have raised concerns about the accuracy of its financial reporting.

SelectQuote, Inc. Legal Issues: SelectQuote is being investigated for allegedly receiving illegal kickbacks from insurers while misrepresenting its services as unbiased, raising significant legal and regulatory concerns regarding its business practices.

Investigation into LuxUrban Hotels: Bragar Eagel & Squire, P.C. is investigating potential claims against LuxUrban Hotels Inc. following a class action complaint alleging that the company misled investors regarding its lease with the Royalton Hotel and failed to disclose multiple lawsuits for unpaid rent.

Stock Price Impact: Following revelations about the lack of a signed lease and ongoing legal issues, LuxUrban's stock price experienced significant declines, dropping 12% on January 17, 2024, and an additional 22% after the company announced the termination of discussions regarding the Royalton Hotel on February 5, 2024.

Earnings Release: LUXURBAN HOTELS ($LUXH) is set to announce its quarterly earnings on March 25th, with analysts predicting revenue of $32.13 million and earnings of $0.04 per share.

Investor Activity: Recent reports indicate that three institutional investors have increased their holdings in LUXURBAN HOTELS, while thirty have reduced their positions in the last quarter.